Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Radient Technologies Inc

Healthcare CA RTI

NoneCAD
0.00(0%)

Last update at 2024-04-09T03:57:51.641912Z

Day Range

--
LowHigh

52 Week Range

0.0050.01
LowHigh

Fundamentals

  • Previous Close -
  • Market Cap2.70M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-4.04093M
  • Revenue TTM3.15M
  • Revenue Per Share TTM0.006
  • Gross Profit TTM -1.09594M
  • Diluted EPS TTM-0.02

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-03-31 2021-03-31 2020-03-31 2019-03-31 2018-03-31
Type yearly yearly yearly yearly yearly
Date 2022-03-31 2021-03-31 2020-03-31 2019-03-31 2018-03-31
Income before tax -12.92998M -42.26583M -37.41774M -27.85557M -14.04832M
Minority interest - - - - -
Net income -12.92998M -42.26583M -37.41774M -27.85557M -14.04832M
Selling general administrative 4.74M 10.15M 20.06M 24.12M 12.36M
Selling and marketing expenses - - - - -
Gross profit 0.19M -0.49561M 0.45M 0.08M 0.19M
Reconciled depreciation 1.71M 2.16M 2.23M 1.13M 0.54M
Ebit -6.45409M -21.29377M -31.61495M -27.88109M -13.63130M
Ebitda -9.27898M -37.51146M -34.35784M -26.28229M -13.31191M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -6.61001M -13.86531M -25.81495M -27.88109M -13.63130M
Other operating expenses - - - - -
Interest expense 1.94M 2.60M 0.83M 0.45M 0.00000M
Tax provision - - - - -
Interest income 0.32M 0.45M 0.23M 0.44M 0.07M
Net interest income -2.35806M -2.78259M -0.77893M -0.21679M -0.38781M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - 0.00000M
Total revenue 3.62M 2.49M 18.40M 0.21M 0.46M
Total operating expenses 10.23M 16.35M 44.22M 28.10M 14.09M
Cost of revenue 3.43M 2.98M 17.96M 0.13M 0.27M
Total other income expense net -3.96191M -25.61793M -10.82386M 0.24M -0.02920M
Discontinued operations - - - - -
Net income from continuing ops -12.92998M -42.26583M -37.41774M -27.85557M -14.04832M
Net income applicable to common shares -12.92998M -42.26583M -37.41774M -27.85557M -14.04832M
Preferred stock and other adjustments - - - - -
Breakdown 2022-03-31 2021-03-31 2020-03-31 2019-03-31 2018-03-31
Type yearly yearly yearly yearly yearly
Date 2022-03-31 2021-03-31 2020-03-31 2019-03-31 2018-03-31
Total assets 27.73M 29.29M 57.93M 61.03M 30.01M
Intangible assets 2.36M 0.60M 0.87M 0.85M 0.08M
Earning assets - - - - -
Other current assets 0.10M 0.39M 0.45M 0.33M 0.86M
Total liab 37.86M 31.82M 38.92M 10.18M 4.14M
Total stockholder equity -10.12578M -2.52987M 19.01M 50.84M 25.87M
Deferred long term liab - - - - -
Other current liab 6.04M 4.72M 8.57M 0.57M 0.20M
Common stock 131.90M 127.13M 112.47M 109.03M 73.28M
Capital stock 131.90M 127.13M 112.47M 109.03M -
Retained earnings -154.09999M -146.67801M -127.28341M -89.86567M -62.01010M
Other liab - - - 0.01M 0.09M
Good will - - - - -
Other assets 0.15M 0.18M 1.63M 1.01M 0.49M
Cash 0.03M 0.49M 0.15M 31.75M 21.86M
Cash and equivalents - - - - -
Total current liabilities 37.70M 31.46M 27.88M 3.70M 2.02M
Current deferred revenue - - - - -
Net debt 12.02M 10.10M 12.90M - -
Short term debt - - - 0.07M 0.22M
Short long term debt 12.05M 10.58M 3.48M 0.07M 0.22M
Short long term debt total - - - - -
Other stockholder equity - - - - -
Property plant equipment 22.63M 25.49M 43.96M 25.34M 4.27M
Total current assets 2.60M 3.02M 11.47M 33.84M 24.05M
Long term investments - - - 0.00000M 1.12M
Net tangible assets -12.48205M -3.13422M 18.14M 50.00M 25.79M
Short term investments - - - - -
Net receivables 0.14M 0.49M 0.85M 0.20M 0.24M
Long term debt - - 9.57M 6.39M 1.85M
Inventory 2.12M 1.39M 8.89M 0.41M 0.03M
Accounts payable 17.11M 14.61M 14.73M 2.96M 1.50M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 0.00000M 0.20M 27.19M 5.97M
Deferred long term asset charges - - - - -
Non current assets total 25.14M 26.27M 46.46M 27.19M 5.97M
Capital lease obligations 1.60M 1.32M 1.96M 0.19M 0.29M
Long term debt total - - - - -
Breakdown 2022-03-31 2021-03-31 2020-03-31 2019-03-31 2018-03-31
Type yearly yearly yearly yearly yearly
Date 2022-03-31 2021-03-31 2020-03-31 2019-03-31 2018-03-31
Investments -1.57830M -0.01422M -11.31650M -13.10610M -1.68171M
Change to liabilities 4.97M 4.66M 8.09M 0.97M 0.34M
Total cashflows from investing activities -1.57830M -0.01422M -11.31650M -13.10610M -1.68171M
Net borrowings 0.10M -0.48435M 6.35M 0.63M -0.31196M
Total cash from financing activities 1.30M 7.32M 6.46M 38.33M 23.32M
Change to operating activities 1.35M -2.05777M 1.25M 0.44M -1.73758M
Net income -12.92998M -42.26583M -37.41774M -27.85557M -14.04832M
Change in cash -0.45367M 0.34M -31.60774M 9.90M 13.35M
Begin period cash flow 0.49M 0.15M 31.75M 21.86M 8.51M
End period cash flow 0.03M 0.49M 0.15M 31.75M 21.86M
Total cash from operating activities -0.17695M -6.96813M -26.74978M -15.32201M -8.29160M
Issuance of capital stock 1.25M 9.63M 0.00771M 34.20M -
Depreciation 1.67M 2.11M 2.19M 1.11M 0.54M
Other cashflows from investing activities - 0.09M -0.19094M -0.09552M -0.35590M
Dividends paid 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change to inventory -0.57178M 0.07M -14.20343M -0.38002M -0.00428M
Change to account receivables 0.38M 0.33M -0.64776M 0.05M -0.15407M
Sale purchase of stock - - - - -
Other cashflows from financing activities -0.04849M -1.81898M -1.63515M -3.06105M 1.72M
Change to netincome 4.44M 28.70M 13.80M 10.08M 6.75M
Capital expenditures 1.58M 0.12M 11.07M 12.30M 1.25M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 6.12M 3.00M -5.51017M 1.08M -1.55646M
Stock based compensation 0.04M 1.57M 2.57M 10.32M -
Other non cash items -0.42995M 3.30M 0.63M 0.24M 0.44M
Free cash flow -1.75524M -7.08796M -37.97553M -28.42599M -9.61741M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
RTI
Radient Technologies Inc		 - -% - - - 0.86 3.15 5.14 -2.0431
RX
Biosyent Inc.		 0.12 0.87% 13.95 19.10 15.85 3.96 4.11 3.31 11.03
DB
Decibel Cannabis Company Inc		 -0.005 4.17% 0.12 - 8.67 0.67 1.20 0.99 17.75
ZYUS
ZYUS Life Sciences Corporation		 - -% 0.50 - - 108.48 4.41 140.29 -4.258
LSL
LSL Pharma Group Inc.		 - -% 0.33 20.75 - 1.88 1.89 2.85 10.19

Reports Covered

Stock Research & News

View All

Profile

Radient Technologies Inc., together with its subsidiaries, processes, manufactures, sells, and distributes cannabis materials in Canada and internationally. It offers vape cartridges or dabs, cannabis oil, standardized cannabinoid ingredients, cannabis extracts, and cannabis formulations. The company also provides extraction services for the extraction, purification, and isolation of cannabinoids for third parties. Its ingredients are used in food and beverage, nutraceuticals, pharmaceuticals, cosmetics, and personal care industries. Radient Technologies Inc. was incorporated in 2001 and is headquartered in Edmonton, Canada.

Radient Technologies Inc

4035 101 Street NW, Edmonton, AB, Canada, T6E 0A4

Key Executives

Name Title Year Born
Dr. Steven Splinter Ph.D. Pres, Interim CEO, Corp. Sec. & Director 1965
Mr. Prakash Hariharan B.Sc., MBA Chief Financial Officer 1972
Mr. Denis M. Taschuk C.A. Advisor 1964
Zachary Riauka Sr. VP of Operations NA
Caitlin Cheadle Director of Communications NA
Dr. David Lafond Ph.D. Managing Director of Global Innovation NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions